<DOC>
	<DOCNO>NCT00602004</DOCNO>
	<brief_summary>The primary objective determine use losartan , angiotensin II receptor blocker , attenuate leave ventricular hypertrophy , independent antihypertensive effect , patient near end stage chronic kidney disease ( CKD ) arteriovenous fistula create . Secondary outcome include impact medication BNP hyperkalaemia</brief_summary>
	<brief_title>Attenuation Cardiac Effects Arteriovenous Fistula Creation With Losartan</brief_title>
	<detailed_description>Study Design : This prospective double blind placebo control 2 arm , randomize ( 1:1 ) parallel group study patient near end stage renal failure require creation arteriovenous fistula future haemodialysis . Enrolment period 12 month . The blinded phase 3 month . The study design summarize Appendix 1 . The study consist screen phase , randomization phase treatment phase . Patients randomize 2 group : - Group 1 Losartan ( 50mg daily blind ) 25 mg atenolol - Group 2 Placebo ( blind ) 25 mg atenolol Patients : Patients must comply specified inclusion exclusion criterion . The number patient use sufficient show 15 % difference leave ventricular mass ( LVM ) two group Study Endpoints : The primary endpoint group difference LVM baseline 1 month . Statistical Considerations : The analysis base upon 'ANCOVA'-type linear regression model include baseline LVM treatment group explanatory variable , final LVM outcome variable .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Arteriovenous Fistula</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>1 . Diagnosis CKD nearend stage renal failure ( CKD Stage IV ) ( eGFR = 1530 mls/min ) . 2 . Age &gt; 18 year age &lt; 85 year age . 3 . Males postmenopausal , sterile woman . Nonpregnant premenopausal woman adequate contraception intention become pregnant duration study . 4 . At baseline TTE LVEF &gt; 45 % 5 . Willing able give inform consent . 1 . Serum potassium level 5.5 mmol/L 2 . Acute myocardial infarction cerebrovascular accident previous 6 month . 3 . Severe uncontrolled hypertension ( diastolic BP &gt; 100mmHg systolic BP &gt; 160 mmHg ) 4 . Evidence suspicion renovascular disease . 5 . Atrial fibrillation 6 . Evidence suspicion collagen disease , cancer , psychiatric disorder interferes patient compliance , drug alcohol abuse , pregnancy , breast feeding ineffective contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Arteriovenous fistula</keyword>
	<keyword>hypertrophy</keyword>
	<keyword>losartan</keyword>
</DOC>